1. Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment
   MINMIN LI et al, 2016 CrossRef
2. null
   Natasa Polak et al, 2018 CrossRef
3. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
   Hiroto Saito et al, 2018, Gastric Cancer CrossRef
4. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
   Ellen Puré et al, 2018, Oncogene CrossRef
5. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations
   M.M. Koczorowska et al, 2016 CrossRef
6. Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice
   Evzen Krepela et al, 2017, Biochemical and Biophysical Research Communications CrossRef
7. Mechanical behavior of metastatic vertebrae are influenced by tissue architecture, mineral content, and organic feature alterations
   Mikhail Burke et al, 2018, J. Orthop. Res. CrossRef
8. Fibroblast activation protein (FAP) as a possible target of the antitumor strategy
   V. V. Pleshkan et al, 2016, Mol. genet. mikrobiol. virusol. CrossRef
9. Missed Druggable Cancer Hallmark: Cancer-Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy
   Eugene Sverdlov, 2018, BioEssays CrossRef
10. Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
    Hajime Kashima et al, 2019, Int J Cancer CrossRef
11. Emerging Potential of Cancer Therapy—Binary Direct Interactions of Cancer and Stromal Cells
    I. V. Alekseenko et al, 2018, Russ J Genet CrossRef
12. Cancer–stroma interactions as a target for cancer treatment.
    I. V. Alekseenko et al, 2018, Biopolym. Cell CrossRef
13. Stroma in normal and cancer wound healing
    Eric Huet et al, 2019, FEBS J CrossRef
14. null
    Natasa Polak et al, 2016 CrossRef
15. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
    Julio Calvete et al, 2019, Human Pathology CrossRef
16. Quantitative evaluation of the intratumoral distribution of platinum in oxaliplatin‐treated rectal cancer: In situ visualization of platinum via synchrotron radiation X‐ray fluorescence spectrometry
    Ryo Koba et al, 2019, Int. J. Cancer CrossRef
17. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma.
    Rafael Pulido, 0 CrossRef
18. Cancer Stem Complex, Not a Cancer Stem Cell, Is the Driver of Cancer Evolution
    E. D. Sverdlov et al, 2019, Biochemistry Moscow CrossRef
19. Cell surface–anchored serine proteases in cancer progression and metastasis
    Carly E. Martin et al, 2019, Cancer Metastasis Rev CrossRef
20. Fibroblast activation protein (FAP) as a possible target of an antitumor strategy
    V. V. Pleshkan et al, 2016, Mol. Genet. Microbiol. Virol. CrossRef
21. Novel immune‐modulating drugs for advanced head and neck cancer
    Tien‐Hua Chen et al, 2019, Head & Neck CrossRef
22. Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein
    Raphaël De Matos et al, 2019, RSC Adv. CrossRef
23. Discovery of covalent prolyl oligopeptidase boronic ester inhibitors
    Jessica Plescia et al, 2019, European Journal of Medicinal Chemistry CrossRef
24. Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
    Kelsie E. Oatmen et al, 2019, Nat Rev Cardiol CrossRef
25. Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models
    Meihua Chen et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
26. Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma
    Johannes Byrling et al, 2020, Scandinavian Journal of Gastroenterology CrossRef
27. null
    Eva Rahman Kabir et al, 2019 CrossRef
28. Are Synapse-Like Structures a Possible Way for Crosstalk of Cancer with Its Microenvironment?
    Irina V Alekseenko et al, 2020, Cancers CrossRef
29. The application of the fibroblast activation protein α-targeted immunotherapy strategy
    Guan-Min Jiang et al, 2016, Oncotarget CrossRef
30. null
    Lizhe Zhuang et al, 2020 CrossRef
31. Cancer‑associated fibroblast stimulates cancer cell invasion in an interleukin‑1 receptor (IL‑1R)‑dependent manner
    Xianglan Zhang et al, 2019, Oncol Lett CrossRef
32. Cancer‑associated fibroblast regulation of tumor neo‑angiogenesis as a therapeutic target in cancer (Review)
    Fang‑Tao Wang et al, 2019, Oncol Lett CrossRef
33. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
    Euy Sung Moon et al, 2020, EJNMMI radiopharm. chem. CrossRef
34. Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance via CXCL12/CXCR4
    Anna Aronovich et al, 2020, Journal of Investigative Dermatology CrossRef
35. AND-gate contrast agents for enhanced fluorescence-guided surgery
    John C. Widen et al, 2020, Nat Biomed Eng CrossRef
36. Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours
    Jon Danel Solano-Iturri et al, 2020, Cancers CrossRef
37. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules
    Stephanie L. Slania et al, 2021, J. Med. Chem. CrossRef
38. In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes
    Yentl Van Rymenant et al, 2021, Front. Chem. CrossRef
39. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma
    Yinghao Meng et al, 2021, J Magn Reson Imaging CrossRef
40. The Latest Developments in Imaging of Fibroblast Activation Protein
    Annette Altmann et al, 2021, J Nucl Med CrossRef
41. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
    Tadashi Watabe et al, 2020, J Nucl Med CrossRef
42. Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
    Catherine Meyer et al, 2020, J Nucl Med CrossRef
43. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging
    Katharina Dendl et al, 2021, PET Clinics CrossRef
44. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis
    Martina Sollini et al, 2021, Eur J Nucl Med Mol Imaging CrossRef
45. CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.
    Sara Labiano et al, 2021, Clin Cancer Res CrossRef
46. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer
    Tamotsu Sugai et al, 2021, Histopathology CrossRef
47. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model
    Yuwei Liu et al, 2021, Eur J Nucl Med Mol Imaging CrossRef
48. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
    Katharina Dendl et al, 2021, Cancers CrossRef
49. New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
    Surachet Imlimthan et al, 2021, Pharmaceuticals CrossRef
50. Potential Targets Other than PSMA for Prostate Cancer Theranostics: A Systematic Review
    Mathieu Gauthé et al, 2021, JCM CrossRef
51. Preparation and Bioevaluation of 99mTc-Labeled FAP Inhibitors as Tumor Radiotracers to Target the Fibroblast Activation Protein
    Qing Ruan et al, 2021, Mol. Pharmaceutics CrossRef
52. [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT
    Rong Lin et al, 2022, Eur J Nucl Med Mol Imaging CrossRef
53. Cancer-associated fibroblasts and FAP-Alpha: Its applications in odontogenic tissues
    Sandhya Tamgadge et al, 2022, J Datta Meghe Inst Med Sci Univ CrossRef
54. Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma
    Danni Li et al, 2022, J Transl Med CrossRef
55. From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi
    Lukas Greifenstein et al, 2022, Pharmaceuticals CrossRef
56. Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements
    M. Dabir et al, 2022, Mol Imaging Biol CrossRef
57. Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
    Narges Jokar et al, 2022, Clin Transl Imaging CrossRef
58. Usefulness of [68Ga]FAPI-04 and [18F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study
    Chongjiao Li et al, 2022, Eur Radiol CrossRef
59. FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease
    Yuriko Mori et al, 2023, Radiology CrossRef
60. Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
    Arun Prashanth et al, 2023 CrossRef
61. Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
    Sedigheh Shahvali et al, 2023, Drug Deliv. and Transl. Res. CrossRef
62. Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors
    Nicole Dmochowska et al, 2023, Small CrossRef
63. Fibroblast Activation Protein Inhibitor Theranostics
    Rainer Hamacher et al, 2023, PET Clinics CrossRef
64. Response Prediction Using18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    Xinying Hu et al, 2023, J Nucl Med CrossRef
65. Noninvasive Assessment of Renal Fibrosis of Chronic Kidney Disease in Rats by [68Ga]Ga-FAPI-04 Small Animal PET/CT and Biomarkers
    Haixia Mao et al, 2023, Mol. Pharmaceutics CrossRef
66. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
    Zahra Kalaei et al, 2023, Cell Commun Signal CrossRef
67. Rapid tumor detection via a fibroblast activation protein-alpha activated fluorogenic probe
    Cheng-Yu Fan et al, 2023, Dyes and Pigments CrossRef
68. Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis
    Kayisaier Abudurousuli et al, 2023 CrossRef
69. Automated Synthesis of [68Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
    Elisabeth Plhak et al, 2023, Pharmaceuticals CrossRef
70. null
    Dipanjan Ghosh et al, 2024 CrossRef
71. Development of covalent inhibitors: Principle, design, and application in cancer
    Lang Zheng et al, 2023, MedComm – Oncology CrossRef
72. Fibroblast Activation Protein: Pivoting Cancer/Chemotherapeutic Insight Towards Heart Failure
    John Gehris et al, 2023, Biochemical Pharmacology CrossRef
73. Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology
    Xin Ji et al, 2023, Chemical & Biomedical Imaging CrossRef
74. 18F-FAPI-04 PET/CT parameters predict PD-L1 expression in esophageal squamous cell carcinoma
    Yaqing Zhao et al, 2023, Front. Immunol. CrossRef
75. Fibroblast Activation Protein–Targeted PET/CT with Al18F-NODA-FAPI-04 for In Vivo Imaging of Tendon Healing in Rat Achilles Tendon Injury Models
    Zhenfeng Liu et al, 2023, Am J Sports Med CrossRef
76. FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
    Kun Jiang et al, 2023, Cancer Cell Int CrossRef
77. Nano-drug delivery system targeting FAP for the combined treatment of oral leukoplakia
    Ran Li et al, 2024, Drug Deliv. and Transl. Res. CrossRef
78. RADIOPHARMACEUTICALS BASED ON FIBROBLAST ACTIVATION PROTEIN INHIBITORS IN ONCOLOGICAL PRACTICE
    D. O. Dzhuzha et al, 2023, Probl Radiac Med Radiobiol CrossRef
79. Molecular imaging for evaluation of synovitis associated with osteoarthritis: a narrative review
    Kwanghoon Lee et al, 2024, Arthritis Res Ther CrossRef
80. null
    Yuriko Mori et al, 2024 CrossRef
81. Development of a Synthetic Method for [68Ga]Ga-FAPI-04 Using a Cassette-based Synthesizer
    Jun Young PARK et al, 2024, Korean J Clin Lab Sci CrossRef
82. Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review)
    Zixing Kou et al, 2024, Int J Oncol CrossRef
83. Carborane-FAPI Conjugate: A Potential FAP-targeted Boron Agent with Improved Boron Content
    Juan Zhang et al, 2024, Applied Radiation and Isotopes CrossRef